JAGUAR HEALTH, INC. Increase (Decrease) in Other Noncurrent Assets
JAGUAR HEALTH, INC. (JAGX) reported Increase (Decrease) in Other Noncurrent Assets of -$26.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-19
- JAGUAR HEALTH, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $11.00K.
- JAGUAR HEALTH, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$37.00K.
- JAGUAR HEALTH, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$1.06M, a 21400.00% decline year-over-year.
- JAGUAR HEALTH, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$2.00K, a 100.19% decline year-over-year.
- JAGUAR HEALTH, INC. increase (decrease) in other noncurrent assets for fiscal 2025 was -$1.17M, a 449.11% decline from fiscal 2024.
- JAGUAR HEALTH, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was $336.00K, a 1876.47% increase from fiscal 2023.
- JAGUAR HEALTH, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was $17.00K.
- JAGUAR HEALTH, INC. increase (decrease) in other noncurrent assets for fiscal 2020 was -$893.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 3 month as first filed | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month | Increase (Decrease) in Other Noncurrent Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | -$26.00K 10-Q · filed 2026-08-19 | -$1.09M derived: sum of 3 quarters · filed 2026-08-19 | -$1.09M derived: sum of 4 quarters · filed 2026-08-19 | ||
| 2026-03-31 | -$37.00K 10-Q · filed 2026-05-20 | -$1.10M derived: sum of 2 quarters · filed 2026-05-20 | -$1.10M derived: sum of 3 quarters · filed 2026-05-20 | |||
| 2025-12-31 | -$1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | -$1.07M derived: sum of 2 quarters · filed 2026-04-07 | -$1.17M 10-K · filed 2026-04-07 | |||
| 2025-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$108.00K 10-Q · filed 2025-11-14 | ||||
| 2025-06-30 | -$106.00K 10-Q · filed 2026-08-19 | |||||
| 2024-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07 | $1.07M derived: sum of 2 quarters · filed 2026-04-07 | $1.07M derived: sum of 3 quarters · filed 2026-04-07 | $336.00K 10-K · filed 2026-04-07 | ||
| 2024-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.07M derived: sum of 2 quarters · filed 2025-11-14 | $331.00K 10-Q · filed 2025-11-14 | $328.00K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$736.00K 10-Q · filed 2025-08-14 | -$739.00K derived: sum of 3 quarters · filed 2025-08-14 | -$735.00K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | -$735.00K 10-Q · filed 2025-05-15 | -$738.00K derived: sum of 2 quarters · filed 2025-05-15 | -$734.00K derived: sum of 3 quarters · filed 2025-05-15 | -$736.00K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.00K derived: sum of 2 quarters · filed 2025-03-31 | -$1.00K derived: sum of 3 quarters · filed 2025-03-31 | $17.00K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $2.00K derived: sum of 2 quarters · filed 2024-11-13 | $20.00K 10-Q · filed 2024-11-13 | |||
| 2023-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $16.00K 10-Q · filed 2024-08-13 | ||||
| 2023-03-31 | $18.00K 10-Q · filed 2024-05-14 | |||||
| 2022-09-30 | $89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.39M derived: sum of 2 quarters · filed 2023-11-14 | $1.40M 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.31M 10-Q · filed 2023-08-14 | ||||
| 2022-03-31 | $5.00K 10-Q · filed 2023-05-15 | |||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$19.00K derived: sum of 2 quarters · filed 2022-11-14 | -$37.00K 10-Q · filed 2022-11-14 | -$842.00K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | -$37.00K 10-Q · filed 2022-08-22 | -$842.00K derived: sum of 3 quarters · filed 2022-08-22 | -$872.00K derived: sum of 4 quarters · filed 2022-08-22 | ||
| 2021-03-31 | -$18.00K 10-Q · filed 2022-05-10 | -$823.00K derived: sum of 2 quarters · filed 2022-05-10 | -$853.00K derived: sum of 3 quarters · filed 2022-05-10 | -$884.00K derived: sum of 4 quarters · filed 2022-05-10 | ||
| 2020-12-31 | -$805.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$835.00K derived: sum of 2 quarters · filed 2021-11-17 | -$866.00K derived: sum of 3 quarters · filed 2021-11-17 | -$893.00K 10-K · filed 2021-03-31 | ||
| 2020-09-30 | -$30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-17 | -$61.00K derived: sum of 2 quarters · filed 2021-11-17 | -$88.00K 10-Q · filed 2021-11-17 | |||
| 2020-06-30 | -$31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$58.00K 10-Q · filed 2021-08-13 | ||||
| 2020-03-31 | -$27.00K 10-Q · filed 2021-05-17 | |||||
| 2019-12-31 | -$109.00K 10-K · filed 2021-03-31 | -$108.69K 10-K · filed 2020-04-03 | ||||
| 2019-03-31 | -$27.00K 10-Q · filed 2020-05-15 | -$27.17K 10-Q · filed 2019-05-21 | -$54.17K derived: sum of 2 quarters · filed 2020-05-15 | |||
| 2018-12-31 | -$27.17K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | $262.66K 10-K · filed 2020-04-03 | ||||
| 2018-09-30 | $289.83K 10-Q · filed 2019-11-14 | |||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-10 | -$122.16K 10-K · filed 2019-04-10 | ||||
| 2017-09-30 | -$122.16K 10-Q · filed 2018-11-19 | |||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-15 | $0.00 derived: sum of 2 quarters · filed 2017-02-15 | $122.16K 10-K · filed 2017-02-15 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $122.16K 10-Q · filed 2016-11-14 | ||||
| 2015-06-30 | $122.16K 10-Q · filed 2016-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |